Technology and Biotech lead with numerous strong buy ratings over the past three days. Key upgrades include AMAT, VEEV, and NTAP in tech, with MESO and EYPT strong in biotech. Energy also sees new strong buys for APA and CTRA. Average target prices suggest continued momentum. Conversely, consumer discretionary and some energy names like SHEL face downgrades on Tuesday and Wednesday, urging selective caution.
Disclaimer: This article is for informational purposes only and does not constitute financial advice. We are not financial professionals. The authors and/or site operators may hold positions in the companies or assets mentioned. Always do your own research before making financial decisions.
Ed Liston is a senior contributing editor at TheStockMarketWatch.com. An active market watcher and investor, Ed guides an independent team of experienced analysts and writes for multiple stock trader publications.